Animal experiments showed that serum levels of interleukin (IL)-2 and In- terferon γ (IFN-γ) were significantly increased in HCC H22 cell-bearing mice treated with GRg3, and stimulated ConA, induced lymphocyte proliferation, and enhanced immunity (Wu et al., 2014). This evidence concerns the gene TLE3 and hepatocellular carcinoma.